Applied DNA Sciences makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT®” platform can be used to identify, tag, track, and trace products, to help assure authenticity, origin, traceability and quality of products. SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track- and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.
The Applied DNA Sciences Inc. corporate headquarters are located at:
50 Health Sciences Drive
Stony Brook, NY 11790
Applied DNA Sciences is a Delaware corporation.
Applied DNA Sciences fiscal year ends September 30.
Applied DNA Sciences common stock is traded on The NASDAQ Capital Market under the ticker symbol APDN.
Applied DNA Sciences warrants are traded on the OTC Markets under the ticker symbol APPDW.
10 Melville Park Road
Tel: 631 414 4000
Fax: 631 414 4001
American Stock Transfer & Trust Company, LLC.
6201 15th Avenue
Brooklyn, New York 11219
Tel: (800) 937-5449 OR (718) 921-8124
The transfer agent is responsible for maintaining all records of stockholders (including change of address, telephone number and name), cancelling or issuing stock certificates, and resolving problems related to lost, destroyed or stolen certificates.
No, Applied DNA Sciences does not offer a direct stock purchase plan. All purchases of stock must be made in the public market.
No, Applied DNA Sciences does not pay dividends at this time.
SEC filings are available at the following address: SEC Filings
Sanjay M. Hurry
Executive Director, Investor Relations and Corporate Communications